W.G. Shaheen & Associates Dba Whitney & CO Astrazeneca PLC Transaction History

W.G. Shaheen & Associates Dba Whitney & CO

$910 Million
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 07, 2019	SELL	$36.86 - $41.49 $18,503 - $20,827	-502 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $17,449 - $19,939	502 New	502 $20,000

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

476M

Call Options Held

6.08M

Put Options Held

4.44M

Price T Rowe Associates Inc Baltimore, MD

60.4M
Shares

$4.44 Billion
0.46% of portfolio
Primecap Management CO Pasadena, CA

41M
Shares

$3.01 Billion
2.12% of portfolio
Capital International Investors Los Angeles, CA

37.5M
Shares

$2.76 Billion
0.48% of portfolio
Bank Of America Corp Charlotte, NC

24M
Shares

$1.77 Billion
0.13% of portfolio
Franklin Resources Inc San Mateo, CA

19.5M
Shares

$1.43 Billion
0.37% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of W.G. Shaheen & Associates Dba Whitney & CO, based on Form 13F filings with the SEC.

News

Stay updated on W.G. Shaheen & Associates Dba Whitney & CO with notifications on news.

Account